We investigated whether killer cell immunoglobulin-like receptor (KIR) genes are risk factor(s) for rheumatoid arthritis (RA) and its clinical manifestations. One hundred and seventy-seven RA patients and 243 healthy individuals were tested for the presence of 11 KIR genes using PCR-SSP method. The frequencies of KIRs in patients with RA were similar to the frequencies in controls. However, RA patients positive for KIR2DL3 and negative for KIR2DS3 had earlier disease diagnosis. Additionally, KIR2DL2 and KIR2DS2 were significantly more frequent among RA patients with extra-articular manifestations and in its subgroup with vasculitis than in controls and in patients without these complications. Furthermore, the frequencies of KIR2DS1 and KIR3DS1 were lower in patients without bone erosions compared with healthy individuals. Relationships between the presence or absence of autoantibodies (rheumatoid factor and anti-cyclic citrullinated peptide) and KIR frequencies were also evaluated, but no significant differences were observed. These results suggest that particular clinical manifestations of RA may have different genetic backgrounds with respect to KIR genotype.
Introduction
Rheumatoid arthritis (RA) is a chronic systemic inflammatory polyarthritis affecting about 1% of individuals in Caucasian populations, and T cells contribute to its initiation. 1, 2 There is a tendency for RA to run in families, and the genetic contribution to disease susceptibility has been estimated at around 60%. 3 One important genetic factor is so-called 'shared epitope' present on several allomorphs of the human leukocyte antigen (HLA) class II, HLA-DR. However, RA is a multifactorial disease, and several other genes are implicated in susceptibility to this condition. 2 Recently, the involvement of natural killer (NK) cells 4, 5 and NKT cells 6 in RA was also described. NK cells kill target cells that have no or substantially reduced cellsurface expression of HLA class I molecules due to viral infection or malignant transformation and immunoselection. Receptors recognizing self HLA class I molecules belong to the C-type lectin and immunoglobulin superfamilies, the former being almost monomorphic and recognizing monomorphic HLA epitopes. In contrast, the latter, called killer cell immunoglobulin-like receptors (KIRs), are highly polymorphic and recognize relatively polymorphic HLA epitopes. [7] [8] [9] KIRs, originally discovered on NK cells, are also present on subpopulations of T lymphocytes. 10 ,11 KIR molecules exist as two or three immunoglobulin-likedomain inhibitory receptors with a long cytoplasmic tail (KIR2DL or KIR3DL) and activating receptors with a short cytoplasmic tail (KIR2DS or KIR3DS). 7, 8 A peculiarity of the KIR genetic system is its haplotypic polymorphism, that is, individuals differ both in number and in kind (inhibitory vs activating) of KIR genes in their genotype. Generally, KIR haplotypes are divided into two groups. Group A contains KIR2DL1, KIR2DL3, KIR3DL1 and some other inhibitory genes and only one activating gene, KIR2DS4, defective in the majority of Caucasians when present. Group B haplotypes are characterized by the presence of at least one functional activating KIR gene other than KIR2DS4. 8, 9, 12 As a consequence of the cellular distribution of their products, KIR genes and A or B KIR haplotypes were found to be associated with several diseases where NK or T cells play a role. 8, 9, 13 One of these conditions is RA, where an unusual subpopulation of CD4 þ CD28 À KIR þ T cells was observed. 11, [14] [15] [16] [17] In this disease, the expression of KIR2DS2 molecule on CD4 þ CD28 À KIR þ T cells and an association of KIR2DS2 gene with vascular inflammatory complication were discovered. 16 Here, we examined whether vasculitis and other complications of RA could also be associated with some KIR genes in the Polish population.
Results
When KIR gene frequencies in controls and patients were compared, no significant differences were observed (Table 1) . Originally, our typing using primers described by Łuszczek et al. 18, 19 revealed relatively high representation of unusual genotype containing KIR2DL3 gene in the absence of KIR2DL1. Retyping of all KIR2DL1-negative samples with recently described primers 20 revealed the presence of KIR2DL1 gene in all KIR2DL3-positive samples, whereas KIR2DL3-negative individuals persisted negative expect for one 2DL1 þ 2DL3 À control person.
KIR2DS3-positive patients were diagnosed later (51.0714.0) than KIR2DS3-negatives (45.6713.5, P ¼ 0.025). On the other hand, KIR2DL3 gene was associated with earlier disease diagnosis (46.4713.6 for positives vs 55.4713.8 for negatives, P ¼ 0.012). Moreover, both KIR2DL2 and KIR2DS2 gene frequencies were increased in RA patients presenting extra-articular manifestations (significant differences in comparisons with both controls and RA patients without these complications, Table 2 ). When patients with extraarticular manifestations were divided into subgroups of those with vasculitis and those with other complications, the former had KIR2DL2 and KIR2DS2 frequencies, which were significantly different from those of controls ( Table 2 ). The frequencies of these two genes in the patients with other extra-articular complications were only slightly increased in comparison with controls. Interestingly, RA patients without any extra-articular lesions had significantly lower KIR2DL2 and KIR2DS2 frequencies than patients with extra-articular manifestations and patients with vasculitis. Although patients without extra-articular lesions were also different from patients with extra-articular manifestations other than vasculitis and from controls, but the significance of these differences disappeared after correction for multiple comparisons (Table 2) .
Moreover, KIR2DS1 and KIR3DS1 gene frequencies were decreased in patients without erosive disease in comparisons with controls and with patients exhibiting erosive disease, but again the significance disappeared after correction (Table 3) .
Finally, no associations between KIR genes and the presence of rheumatoid factor or anti-cyclic citrullinated peptide (anti-CCP) antibodies were found, except for a weak nonsignificant (P ¼ 0.07) increase of KIR2DS4del frequency in rheumatoid factor-negative patients ( Table 2 ).
Discussion
Our results suggest that the mere susceptibility to RA is independent of KIR genotype. However, the presence of KIR2DL3 and, to a lower degree, the absence of KIR2DS3 seem to favor earlier disease onset. It should be kept in mind, however, that the date of diagnosis may sometimes be remarkably delayed in relation to the onset of symptoms due to the waiting time for a hospital appointment.
2 Therefore, the age at disease onset might have been imprecisely determined in some cases. The association of inhibitory KIR2DL3 and an apparent protective effect of activating KIR2DS3 gene may seem surprising. However, it may result from the presence of these KIRs on regulatory rather than on effector cells contributing to the disease.
In addition, particular clinical manifestations in our patient group seemed to be associated with some KIR genes. Thus, although the frequencies of KIR2DS1 and KIR3DS1 were similar in patients with erosive articular lesions and in controls, they were decreased (nonsignificantly after correction) in patients without these lesions. An explanation for these unexpected findings may be that both genes do not contribute to susceptibility to RA, but once a person has developed the disease, the presence of a given activating KIR predisposes her/him to the development of its particular manifestation(s).
Although susceptibility to RA did not appear to be associated with KIR genotype (see above), extra-articular manifestations were strongly associated with KIR2DL2 and KIR2DS2. Subdivision of patients with these complications into those with vasculitis and those with other extra-articular manifestations revealed that vasculitis was the major factor responsible for the association. Yen et al. 16 observed frequent expression of activating
T cells in rheumatoid vasculitis, and they therefore compared the frequencies of KIR2DS1 and KIR2DS2 genes in RA patients with and without vasculitis. As a result, they found a significantly increased frequency of KIR2DS2, but not of KIR2DS1, in RA vasculitis patients. Other KIR genes were not tested there. We confirm here their result for KIR2DS2 (highly significant association with RA vasculitis) and extend it to KIR2DL2, which was equally strongly associated with this complication.
The differences between the distinct clinical manifestations of RA in KIR associations require a comment. The fraction of CD4 þ CD28 À T lymphocytes is increased in RA vasculitis in comparison with other clinical forms of RA. 14, 16, 17 Both T and NK cells are involved in RA pathology, [1] [2] [3] [4] but their contribution to different manifestations of the disease is largely unknown. Moreover, the mechanisms of KIR inhibitory and activatory functions in T cells are different from those in NK cells. 21, 22 Therefore, distinct KIRs may contribute to different forms of RA. Disease manifestations other than vasculitis had lost significant associations with KIRs after correction (Tables 2 and 3 ). Therefore, these observations need to be replicated, in the same or other populations, in order to be confirmed.
To the best of our knowledge, there are only two studies on possible associations of multiple KIR genes with RA published so far. Middleton et al., 23 similar to our study, found no differences in KIR gene frequencies between Northern Irish RA patients and controls. In addition, stratification of the patients according to gender, KIR ligand or HLA-DR shared epitope did not reveal any association with KIR. On the other hand, Yen et al., 24 in contrast to Middleton's 23 and our data on Caucasians, found significant associations of KIR2DS4 and KIR2DL1 with RA in a Taiwanese Chinese (Han) population. The discrepancy between Taiwanese and Caucasians in KIR associations with RA susceptibility may have at least two reasons.
First, both populations are genetically fairly distant, differing in both HLA and KIR haplotype composition and frequencies. [25] [26] [27] [28] [29] Therefore, gene-disease associations in Caucasians and Chinese may be different, as has already been described in several other diseases. 
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Second, KIR2DS4 alleles present in human populations fall into two categories: normal, non-defective full-length gene (2DS4fl) and a gene with a 22-bp deletion resulting in a putative soluble protein product with only one immunoglobulin domain (2DS4del). 29 The 2DS4del form prevails in KIR2DS4-positive Caucasians, 30, 31 whereas the opposite is true for Oriental populations. 28, 32 Yen et al. 24 did not differentiate between 2DS4fl and 2DS4del alleles, so the nature of their RA-associated KIR2DS4 molecule (cell membrane-activating receptor vs soluble 2DS4del protein, possibly masking a ligand for 2DS4fl and other receptors) is not known. It therefore seems premature to speculate on the role of KIR2DS4 in the Taiwanese' susceptibility to RA.
In conclusion, this is the first study showing KIR gene associations with different clinical manifestations of RA in addition to an earlier report 16 on KIR2DS2 in RA vasculitis. Our results suggest different genetic backgrounds for the distinct manifestations of RA. The subjects enrolled in the study underwent routine biochemical blood analysis and also assays for anticardiolipin antibodies, antinuclear antibodies and immunological complexes when required. X-rays of the chest, hands and feet were obtained in all patients and, when required, radiographs of other joints. These were interpreted by two expert radiologists. The evaluation of the subjects included physical examination, with particular focus on the pattern of joint involvement and the presence of extra-articular features (such as vasculitis, anemia, sicca syndrome, amyloidosis, organ involvement), and laboratory features, such as rheumatoid factor and anti-CCP screened for with the use of respective ELISA kits. Amyloidosis was diagnosed by histomorphology (skin and bowel or duodenum biopsy), vasculitis by histomorphology (skin biopsy) and angiogram. The clinical characteristics of the patients are given in Table 3 . The clinical features listed in the table overlapped, that is, most patients presented more than one. For example, many patients with erosive disease of the joints also had extra-articular manifestations.
Patients and methods

Patients and controls
Blood samples from 243 unrelated healthy volunteers (119 women and 124 men, age: 43.1715.9 years, range: 19-83 years) were taken for control. Both the patients and the controls were Caucasians from the western Pomerania region of Poland. The project was approved by the Ethics Committee of the Pomeranian Medical University in Szczecin. Signed informed consent was obtained from all persons tested.
DNA isolation
Genomic DNA was extracted manually as described by Gustincich et al. 33 Briefly, it comprised precipitation with trimethylammonium bromide salts from leukocytes contained in 450 ml of venous blood with ethylene diamine tetraacetic acid as an anticoagulant. DNA was then precipitated in 95% ethanol, dissolved in distilled water and stored at À201 C until analysis.
KIR genotyping
This was performed by polymerase chain reaction using sequence-specific primers and analyzed as described previously. 18, 19 Samples typed negative for KIR2DL1 were retyped using new primers of Vilches et al.
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Statistical analysis Differences between controls, patients and patient subgroups were estimated using the two-tailed Fisher's exact test and GraphPad InStat 3 software. The correction of P-values (if o0.05) for the number of comparisons (11 genes and 7 or 3 subgroups of patients) was calculated using the formula of Svejgaard and Ryder. 34 
